- 06:52 PM FIIs net sell Rs 68 cr in equities on Nov 23
- 06:38 PM Buy Unity Infra: target of Rs 605: India Capital M...
- 06:26 PM Mkts consolidates after 2 days of strong rally: Ni...
- 06:25 PM Karvy negative on telecom sector
- 06:24 PM Air India saves Rs 400cr through restructuring
- 06:11 PM Unitech gears up for thrid fund raising exercise
- 06:11 PM RIL rangebound between Rs 1,900-2,200: Gujral
- 06:11 PM Reliance reopens 900 gas stations: Official
- 06:07 PM BSNL, MMTC, Manganese Ore next on govt's divestmen...
- 06:04 PM Nifty to see 50-52% rollover ahead of Thursday's e...



Technical Analyst, Vijay Bhambwani is of the view that Ranbaxy Laboratories has support at Rs 325-335.
Bhambwani told CNBC-TV18, "One sees a sign of recovery in Ranbaxy Lab and a sustainable recovery will actually be confirmed after the stock starts trading above Rs 445-450 with heavier volume and increase commitment of traders. At this point in time Rs 325-335 is a support base below which if the stock starts to trade constantly with heavier volumes I think it could signal another phase of either decline or consolidation or linear movement."
|
Stock Advice
|
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Mitesh Thacker's top 5 picks for trade today

- Ganeshaspeaks: Market prediction for Nov 24
- Den Networks slips 22% after listing at Rs 195
- Trading in MF units to start in 15 days: SEBI

- Will ITC dream run continue beyond FY10?

- Why LyondellBasell is a goldmine for RIL

- Experts see mkts at new highs, advise sectors

- Corrections in '10 to be more aggressive, violent: JPMorgan

- Mahindra may increase car prices due to rising input costs
Source: Business Line
- Renault to continue with M&M for Logan, says Ghosn
Source: Business Line
- Market volatility poses valuation problems: IRDA
Source: Business Line
- Punjab, Haryana buck all-India rice decline trend
Source: Business Line










